Anaprox and Dyspepsia aggravated - a phase IV clinical study of FDA data

Summary:

Dyspepsia aggravated is reported as a side effect among people who take Anaprox (naproxen sodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Cephalexin, and have Hepatitis c.

The phase IV clinical study analyzes which people have Dyspepsia aggravated when taking Anaprox. It is created by eHealthMe based on reports of 1,302 people who have side effects when taking Anaprox from the FDA, and is updated regularly.

What is Anaprox?

Anaprox has active ingredients of naproxen sodium. eHealthMe is studying from 1,370 Anaprox users. Check the latest studies of Anaprox.

What is Dyspepsia aggravated?

Dyspepsia aggravated (indigestion) is found to be associated with 1,908 drugs and 513 conditions by eHealthMe. Check the latest studies of Dyspepsia aggravated.

On Jul, 15, 2026

1,302 people reported to have side effects when taking Anaprox.
Among them, 29 people (2.23%) have Dyspepsia aggravated.

Could Anaprox cause Dyspepsia aggravated?

Among these 29 people:

How long have people been on Anaprox when they have Dyspepsia aggravated? *

What is the gender of people who have Dyspepsia aggravated when taking Anaprox? *

female: 96.3 %
male: 3.7 %

What is the age of people who have Dyspepsia aggravated when taking Anaprox? *

What are other drugs people take besides Anaprox? *

What are other side effects people have besides Dyspepsia aggravated? *

Nausea (feeling of having an urge to vomit): 19 people, 65.52%
Drug Ineffective: 15 people, 51.72%
Chest Pain: 12 people, 41.38%
Pain: 12 people, 41.38%
Pain In Extremity: 11 people, 37.93%
Inflammation: 11 people, 37.93%
Memory Loss: 11 people, 37.93%
Fatigue (feeling of tiredness): 10 people, 34.48%
Joint Pain: 10 people, 34.48%
Vision Blurred: 10 people, 34.48%

What are the existing conditions these people have? *

Hepatitis C: 8 people, 27.59%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.34%
Insomnia (sleeplessness): 3 people, 10.34%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 10.34%
Stress And Anxiety: 2 people, 6.90%
Acne (skin problems that cause pimples): 2 people, 6.90%
Pain: 2 people, 6.90%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 6.90%
Birth Control: 2 people, 6.90%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Anaprox and have Dyspepsia aggravated?

- Check whether Dyspepsia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anaprox:

Anaprox (1,370 reports)

Browse all side effects of Anaprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspepsia aggravated:

Dyspepsia aggravated (1,909 drugs)

Browse all the conditions that are associated with Dyspepsia aggravated:

Dyspepsia aggravated (513 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen sodium (the active ingredients of Anaprox) and Anaprox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.